MUC1 and COVID-19: Ke et al., showed that serum KL-6 in patients with mild-to-moderate COVID-19 were significantly lower (SMD = −0.93; 95%CI: −1.22 to −0.65) than those in severe COVID-19 patients [37], although there was high heterogeneity of data.